176 related articles for article (PubMed ID: 29436617)
21. miR-1908 as a novel prognosis marker of glioma via promoting malignant phenotype and modulating SPRY4/RAF1 axis.
Chai Z; Fan H; Li Y; Song L; Jin X; Yu J; Li Y; Ma C; Zhou R
Oncol Rep; 2017 Nov; 38(5):2717-2726. PubMed ID: 29048686
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of phosphatidylethanolamine binding protein 1 associates with clinical risk factors in gastrointestinal stromal tumors, but not with activation of the RAF-1-MEK-ETV1 pathway.
Schoppmann SF; Beer A; Nirtl N; Ba-Ssalamah A; Brodowicz T; Streubel B; Birner P
Cancer Lett; 2013 Jul; 335(1):26-30. PubMed ID: 23376254
[TBL] [Abstract][Full Text] [Related]
23. Structural basis for RKIP binding with its substrate Raf1 kinase.
Wu Z; Fu C; Shi L; Ruan L; Lin D; Guo C
Biotechnol Lett; 2014 Sep; 36(9):1869-74. PubMed ID: 24863296
[TBL] [Abstract][Full Text] [Related]
24. TAF15 promotes cell proliferation, migration and invasion of gastric cancer via activation of the RAF1/MEK/ERK signalling pathway.
Tang L; Guo C; Li X; Zhang B; Huang L
Sci Rep; 2023 Apr; 13(1):5846. PubMed ID: 37037864
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
Ellenrieder V; Hendler SF; Boeck W; Seufferlein T; Menke A; Ruhland C; Adler G; Gress TM
Cancer Res; 2001 May; 61(10):4222-8. PubMed ID: 11358848
[TBL] [Abstract][Full Text] [Related]
26. Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway.
Tan X; Egami H; Abe M; Nozawa F; Hirota M; Ogawa M
J Clin Pathol; 2005 Dec; 58(12):1242-8. PubMed ID: 16311341
[TBL] [Abstract][Full Text] [Related]
27. Curcumin inhibits H2O2-induced invasion and migration of human pancreatic cancer via suppression of the ERK/NF-κB pathway.
Cao L; Liu J; Zhang L; Xiao X; Li W
Oncol Rep; 2016 Oct; 36(4):2245-51. PubMed ID: 27572503
[TBL] [Abstract][Full Text] [Related]
28. Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway.
Xu Z; Chen S; Liu R; Chen H; Xu B; Xu W; Chen M
Mol Cancer; 2022 Jul; 21(1):146. PubMed ID: 35840930
[TBL] [Abstract][Full Text] [Related]
29. β-N-oxalyl-L-α,β-diaminopropionic acid regulates mitogen-activated protein kinase signaling by down-regulation of phosphatidylethanolamine-binding protein 1.
Jammulamadaka N; Burgula S; Medisetty R; Ilavazhagan G; Rao SL; Singh SS
J Neurochem; 2011 Jul; 118(2):176-86. PubMed ID: 21554319
[TBL] [Abstract][Full Text] [Related]
30. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.
Kim SO; Kim MR
Int J Oncol; 2013 Jan; 42(1):349-58. PubMed ID: 23135610
[TBL] [Abstract][Full Text] [Related]
31. Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway.
Xu X; Zhao Z; Guo S; Li J; Liu S; You Y; Ni B; Wang H; Bie P
Cancer Lett; 2017 Jul; 397():12-22. PubMed ID: 28315433
[TBL] [Abstract][Full Text] [Related]
32. Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study.
Wang MC; Jiao M; Wu T; Jing L; Cui J; Guo H; Tian T; Ruan ZP; Wei YC; Jiang LL; Sun HF; Huang LX; Nan KJ; Li CL
Oncotarget; 2016 Feb; 7(8):9586-99. PubMed ID: 26840020
[TBL] [Abstract][Full Text] [Related]
33. A proteomic approach in investigating the hepatoprotective mechanism of Schisandrin B: role of raf kinase inhibitor protein.
Chen Y; Ip SP; Ko KM; Poon TC; Ng EW; Lai PB; Mao QQ; Xian YF; Che CT
J Proteome Res; 2011 Jan; 10(1):299-304. PubMed ID: 21155602
[TBL] [Abstract][Full Text] [Related]
34. Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study.
Dai H; Chen H; Liu W; You Y; Tan J; Yang A; Lai X; Bie P
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2107-17. PubMed ID: 27444299
[TBL] [Abstract][Full Text] [Related]
35. The transcription factor NFAT1 induces apoptosis through cooperation with Ras/Raf/MEK/ERK pathway and upregulation of TNF-α expression.
Robbs BK; Lucena PI; Viola JP
Biochim Biophys Acta; 2013 Aug; 1833(8):2016-28. PubMed ID: 23583303
[TBL] [Abstract][Full Text] [Related]
36. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
He X; Zheng Z; Li J; Ben Q; Liu J; Zhang J; Ji J; Yu B; Chen X; Su L; Zhou L; Liu B; Yuan Y
Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849
[TBL] [Abstract][Full Text] [Related]
37. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
[TBL] [Abstract][Full Text] [Related]
38. ZNF452 facilitates tumor proliferation and invasion via activating AKT-GSK3β signaling pathway and predicts poor prognosis of non-small cell lung cancer patients.
Zhang X; Zhou H; Zhang Y; Cai L; Jiang G; Li A; Miao Y; Li Q; Qiu X; Wang E
Oncotarget; 2017 Jun; 8(24):38863-38875. PubMed ID: 28418919
[TBL] [Abstract][Full Text] [Related]
39. KIF15 promotes pancreatic cancer proliferation via the MEK-ERK signalling pathway.
Wang J; Guo X; Xie C; Jiang J
Br J Cancer; 2017 Jul; 117(2):245-255. PubMed ID: 28595260
[TBL] [Abstract][Full Text] [Related]
40. Raf1 is a prognostic factor for progression in patients with non‑small cell lung cancer after radiotherapy.
Tian H; Yin L; Ding K; Xia YY; Wang XH; Wu JZ; He X
Oncol Rep; 2018 Apr; 39(4):1966-1974. PubMed ID: 29484414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
